Revenue and margins have been volatile, with the combined ratio ranging from 78.1% to 85.3% over the ten-quarter window and net income swinging between $180.7M and $383.3M, suggesting underwriting quality remains uneven.
AXIS Capital Holdings Limited (AXS) annual income statement — 24-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 |
|---|
| Revenue | 6.92B | 6.56B | 6.02B | 5.59B | 5.3B | 5.32B | 4.76B | 5.19B | 5.12B | 4.44B | 4.13B | 4.23B | 4.45B | 4.17B | 3.9B | 3.85B | 3.57B | 2.79B | 2.81B | 3.23B | 3.08B | 2.79B | 2.21B | 1.56B | 633.57M |
| Revenue Growth % | 10.1% | 9.05% | 7.66% | 5.39% | -0.31% | 11.77% | -8.18% | 1.29% | 15.26% | 7.63% | -2.5% | -4.91% | 6.73% | 7.01% | 1.33% | 7.82% | 28.01% | -0.86% | -12.89% | 4.8% | 10.41% | 26.44% | 41.57% | 145.87% | - |
| Medical Costs & Claims | 3.64B | 3.29B | 4.23B | 4.39B | 4.26B | 3.93B | 4.21B | 4.07B | 4.16B | 4.11B | 2.95B | 2.89B | 2.92B | 2.8B | 2.72B | 3.26B | 2.17B | 1.84B | 2.08B | 1.75B | 1.81B | 2.39B | 1.53B | 920.32M | 332.97M |
| Medical Cost Ratio % | 52.63% | 50.1% | 70.26% | 78.6% | 80.39% | 73.86% | 88.44% | 78.48% | 81.24% | 92.56% | 71.51% | 68.38% | 65.69% | 67.1% | 69.89% | 84.83% | 60.72% | 66.19% | 73.98% | 54.39% | 58.89% | 85.66% | 69.23% | 59.08% | 52.55% |
| Gross Profit | 3.28B | 3.28B | 1.79B | 1.2B | 1.04B | 1.39B | 550.44M | 1.12B | 960.45M | 330.45M | 1.18B | 1.34B | 1.53B | 1.37B | 1.17B | 583.29M | 1.4B | 942.05M | 731.21M | 1.47B | 1.27B | 399.89M | 678.54M | 637.46M | 300.6M |
| Gross Margin % | 47.37% | 49.9% | 29.74% | 21.4% | 19.61% | 26.14% | 11.56% | 21.52% | 18.76% | 7.44% | 28.49% | 31.62% | 34.31% | 32.9% | 30.11% | 15.17% | 39.28% | 33.81% | 26.02% | 45.61% | 41.11% | 14.34% | 30.77% | 40.92% | 47.45% |
| Gross Profit Growth % | - | 82.99% | 49.59% | 15% | -25.19% | 152.67% | -50.68% | 16.2% | 190.65% | -71.9% | -12.14% | -12.36% | 11.31% | 16.91% | 101.17% | -58.37% | 48.74% | 28.83% | -50.31% | 16.27% | 216.53% | -41.07% | 6.44% | 112.06% | - |
| Operating Expenses | 2.04B | 2.05B | 781.53M | 798.03M | 797.25M | 741.87M | 679.57M | 778.64M | 947.91M | 698.56M | 654.08M | 693.65M | 696.57M | 637.37M | 622.84M | 521.75M | 505.76M | 402.19M | 323.72M | 338.16M | 268.85M | 299.38M | 178.11M | 105.79M | 36.91M |
| OpEx / Revenue % | 29.43% | 31.22% | 12.98% | 14.27% | 15.03% | 13.94% | 14.27% | 15.02% | 18.52% | 15.73% | 15.85% | 16.39% | 15.65% | 15.28% | 15.98% | 13.57% | 14.18% | 14.43% | 11.52% | 10.48% | 8.73% | 10.74% | 8.08% | 6.79% | 5.83% |
| Depreciation & Amortization | 98.89M | 56.38M | 55.31M | 75.55M | 68.29M | 66.98M | 65.8M | 75.23M | 9.79M | 31.37M | 24.57M | 26.34M | 24.97M | 23.27M | 13.82M | 16.91M | 14.1M | 14.73M | 11.31M | 29.11M | 40.59M | 41.28M | 36.35M | 12.01M | 11.88M |
| Combined Ratio % | 82.06% | 81.33% | 83.25% | 92.87% | 95.42% | 87.81% | 102.71% | 93.49% | 99.76% | 108.29% | 87.36% | 84.77% | 81.34% | 82.39% | 85.87% | 98.4% | 74.9% | 80.63% | 85.5% | 64.87% | 67.62% | 96.4% | 77.31% | 65.87% | 58.38% |
| Operating Income | 1.24B | 1.23B | 1.01B | 398.44M | 243.13M | 648.91M | -129.13M | 337.45M | 12.54M | -368.11M | 521.8M | 644.66M | 830.47M | 734.47M | 550.53M | 61.54M | 895.4M | 539.86M | 407.49M | 1.13B | 996.9M | 100.51M | 500.44M | 531.67M | 263.69M |
| Operating Margin % | 17.94% | 18.67% | 16.75% | 7.13% | 4.58% | 12.19% | -2.71% | 6.51% | 0.24% | -8.29% | 12.64% | 15.23% | 18.66% | 17.61% | 14.13% | 1.6% | 25.1% | 19.37% | 14.5% | 35.13% | 32.38% | 3.6% | 22.69% | 34.13% | 41.62% |
| Operating Income Growth % | - | 21.56% | 153.04% | 63.88% | -62.53% | 602.51% | -138.27% | 2590.54% | 103.41% | -170.55% | -19.06% | -22.37% | 13.07% | 33.41% | 794.61% | -93.13% | 65.86% | 32.49% | -64.05% | 13.7% | 891.87% | -79.92% | -5.87% | 101.63% | - |
| EBITDA | 1.34B | 1.28B | 1.06B | 474M | 311.41M | 715.89M | -63.34M | 412.68M | 22.34M | -336.74M | 546.38M | 671M | 855.44M | 757.74M | 564.35M | 78.44M | 909.51M | 554.6M | 418.8M | 1.16B | 1.04B | 141.79M | 536.79M | 543.68M | 275.57M |
| EBITDA Margin % | 19.37% | 19.53% | 17.67% | 8.48% | 5.87% | 13.45% | -1.33% | 7.96% | 0.44% | -7.58% | 13.24% | 15.85% | 19.22% | 18.17% | 14.48% | 2.04% | 25.5% | 19.9% | 14.9% | 36.03% | 33.7% | 5.08% | 24.34% | 34.9% | 43.49% |
| Interest Expense | 66.79M | 66.66M | 67.77M | 68.42M | 63.15M | 62.3M | 75.05M | 68.11M | 67.43M | 54.81M | 51.36M | 50.96M | 74.69M | 61.98M | 61.86M | 62.6M | 55.88M | 32.03M | 31.67M | 51.15M | 32.95M | 32.45M | 5.29M | 1.48M | 0 |
| Non-Operating Income | -27.09M | -66.66M | -67.77M | -68.42M | -63.15M | -62.3M | -75.05M | -68.11M | -67.43M | -54.81M | -51.36M | -50.96M | -74.69M | -61.98M | -61.86M | -62.6M | -55.88M | -32.03M | -31.67M | -51.15M | -32.95M | -32.45M | -5.29M | -1.48M | 0 |
| Pretax Income | 1.22B | 1.23B | 1.03B | 402.61M | 245.12M | 680.99M | -132.75M | 337.45M | 12.54M | -368.11M | 521.8M | 644.66M | 830.47M | 734.47M | 550.53M | 61.54M | 895.4M | 539.86M | 407.49M | 1.13B | 996.9M | 100.51M | 500.44M | 531.67M | 263.69M |
| Pretax Margin % | 17.65% | 18.67% | 17.05% | 7.2% | 4.62% | 12.8% | -2.79% | 6.51% | 0.24% | -8.29% | 12.64% | 15.23% | 18.66% | 17.61% | 14.13% | 1.6% | 25.1% | 19.37% | 14.5% | 35.13% | 32.38% | 3.6% | 22.69% | 34.13% | 41.62% |
| Income Tax | 89.78M | 216.73M | -55.59M | 26.32M | 22.04M | 62.38M | -12.32M | 23.69M | -29.49M | -7.54M | 6.34M | 3.03M | 25.91M | 7M | 3.29M | 15.23M | 38.68M | 41.98M | 20.11M | 41.49M | 33.84M | 6.07M | 5.44M | -678K | -1.43M |
| Effective Tax Rate % | 7.35% | 17.68% | -5.42% | 6.54% | 8.99% | 9.16% | 9.28% | 7.02% | -235.1% | 2.05% | 1.22% | 0.47% | 3.12% | 0.95% | 0.6% | 24.75% | 4.32% | 7.78% | 4.93% | 3.66% | 3.39% | 6.04% | 1.09% | -0.13% | -0.54% |
| Net Income | 1.14B | 1.01B | 1.08B | 376.29M | 223.08M | 618.61M | -120.42M | 323.47M | 43.02M | -368.97M | 513.37M | 641.63M | 810.75M | 727.47M | 547.24M | 46.3M | 856.72M | 497.89M | 387.38M | 1.09B | 963.06M | 94.44M | 495M | 532.35M | 265.12M |
| Net Margin % | 16.42% | 15.37% | 17.97% | 6.73% | 4.21% | 11.62% | -2.53% | 6.24% | 0.84% | -8.31% | 12.44% | 15.16% | 18.22% | 17.44% | 14.04% | 1.2% | 24.02% | 17.87% | 13.78% | 33.85% | 31.28% | 3.39% | 22.45% | 34.17% | 41.85% |
| Net Income Growth % | 12.22% | -6.74% | 187.49% | 68.68% | -63.94% | 613.69% | -137.23% | 651.9% | 111.66% | -171.87% | -19.99% | -20.86% | 11.45% | 32.93% | 1081.82% | -94.6% | 72.07% | 28.53% | -64.53% | 13.39% | 919.76% | -80.92% | -7.02% | 100.8% | - |
| EPS (Diluted) | 15.49 | 12.35 | 12.35 | 4.02 | 2.25 | 6.90 | -1.79 | 3.34 | 0.51 | -4.39 | 5.08 | 6.04 | 7.29 | 5.93 | 4.00 | 0.07 | 6.02 | 3.07 | 2.26 | 6.41 | 5.63 | 0.57 | 2.98 | 3.42 | 1.91 |
| EPS Growth % | 22.07% | 0% | 207.21% | 78.67% | -67.39% | 485.47% | -153.59% | 554.9% | 111.62% | -186.42% | -15.89% | -17.15% | 22.93% | 48.25% | 5614.29% | -98.84% | 96.09% | 35.84% | -64.74% | 13.85% | 887.72% | -80.87% | -12.87% | 79.06% | - |
| EPS (Basic) | - | 12.52 | 12.49 | 4.06 | 2.27 | 6.95 | -1.79 | 3.37 | 0.52 | -4.39 | 5.13 | 6.10 | 7.38 | 6.02 | 4.05 | 0.08 | 6.74 | 3.36 | 2.50 | 7.15 | 6.18 | 0.63 | 3.24 | 3.69 | 1.96 |
| Diluted Shares Outstanding | 73.37M | 79.27M | 85.18M | 86.01M | 85.67M | 85.29M | 84.26M | 84.47M | 84.01M | 84.11M | 91.55M | 99.63M | 105.71M | 115.33M | 123.65M | 128.12M | 136.2M | 150.37M | 155.32M | 164.51M | 164.39M | 157.52M | 165.88M | 155.69M | 138.48M |
Quick answers to the most common questions about buying AXS stock.
For fiscal year 2025, AXIS Capital Holdings Limited (AXS) reported total revenue of $6.56B. This represents a 936.0% increase compared to $633.6M in 2002.
AXIS Capital Holdings Limited (AXS) is profitable, generating $1.01B in net income for the fiscal year ending 2025 with a net profit margin of 15.4%.
AXIS Capital Holdings Limited (AXS) reported an operating income of $1.23B, resulting in an operating profit margin of 18.7%. This margin reflects the operational efficiency of the business before interest and taxes.
AXIS Capital Holdings Limited (AXS) generated $3.28B in gross profit for the year, representing a gross profit margin of 49.9%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Catastrophe and social inflation exposure
Metrics are mathematically derived from official filings.
Top Line Growth Outpacing Peak Cycle Pricing
Based on reported quarterly figures, AXS's revenue rose 9.1% year over year to roughly $1.8B in the latest quarter, with its 2026Q2 top line up 13.8%, suggesting premium volume is expanding faster than the recent sequential pace.
Growth appears to be coming from a mix of rate and volume, but the data does not separate the two, so it is unclear how much reflects sustainable pricing versus transactional renewal activity. The deliberate narrowing toward specialty lines may be limiting volume in some periods, which could explain the uneven quarterly pattern. Investors should monitor whether the renewal price index remains above loss-cost inflation, since growth without rate adequacy would weaken the earnings case.
Combined Ratio Swings Reveal Underwriting Volatility
As reported in the income statement, AXS's combined ratio ranged from 78.1% in 2025Q3 to 85.3% in 2026Q3, with loss ratios falling from 71.6% in 2025Q1 to 49.6% in 2025Q4 before partially rebounding.
The sub-90% combined ratios across recent quarters suggest underwriting profitability before investment income, though the swing in loss ratio from roughly 72% to below 50% is large enough to warrant questions about reserve timing and catastrophe load. The rise in the most recent quarter to 85.3% may indicate normalization rather than deterioration, but the data alone cannot distinguish these explanations. Investors should check whether the expense ratio is holding steady, because a rising acquisition cost would erode the underwriting cushion even if losses stay contained.
Earnings Quality Depends on Reserve Development
Based on the quarterly figures provided, the sharp drop in loss ratio from 66.6% in 2025Q3 to 49.6% in 2025Q4 coincides with a period of heavy earnings growth, which may indicate favorable prior-year reserve development.
Prior-year reserve releases can lift reported margins without reflecting current-year underwriting quality, and the timing of the Q4 2025 improvement is consistent with that pattern, though the supplied data does not confirm it. Since reserve development detail is not included in the dataset, any conclusion about earnings quality remains inferential. Investors warrant further investigation into the reserve roll-forward before treating the lower loss ratio as a durable improvement.
Second Half 2025 Loss Ratio Inflection
Reported figures show AXS's loss ratio dropping from 71.6% in 2025Q1 to 49.6% in 2025Q4 while net income climbed from $194.1M to $289.6M, marking the most significant underwriting inflection in the ten-quarter window.
The move from elevated loss ratios in early 2025 to the sub-50% level in late 2025 suggests either a benign catastrophe period or a shift in reserving assumptions, and the data cannot isolate which. The subsequent rebound to 54.9% in 2026Q3 indicates the improvement may not have been fully sustained. Investors should treat the late-2025 inflection cautiously until the cause is established.
Earnings Beat May Reflect Timing Effects
Based on reported EPS, the 2026Q2 result of $5.06 diluted EPS against a sharp 86.0% year-over-year increase may overstate the underlying earnings trajectory given the volatility visible across recent quarters.
The recent EPS beat is notable, but the absence of investment income data and the lack of forward guidance make it difficult to judge whether this quarter is representative. Quarterly EPS fell 26.5% in 2026Q3 from the prior quarter, illustrating how much single-period results can swing. Investors should be cautious about extrapolating a single strong quarter into a durable profitability trend.